Viktoria Enkmann
CEO
R
RNAnalytics
This startup provides an analytical toolkit for characterizing lipid nanoparticles (LNPs) used in mRNA and gene therapies. Their capillary electrophoresis systems measure LNP particle size and RNA encapsulation efficiency, enabling real-time monitoring and optimization of therapeutic development processes.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
- Software Only
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Hannes-Oliver Burgstaller
Product
Problem
The development of RNA-based therapeutics, such as mRNA and gene therapies, requires precise analytical tools to characterize lipid nanoparticles (LNPs). Traditional methods for LNP characterization can be cumbersome, require significant investment in new equipment, and may not integrate easily into existing laboratory workflows. This can lead to bottlenecks in development, hindering project progress and regulatory acceptance.
Solution
RNAnalytics provides a modular analytical platform for characterizing lipid nanoparticles (LNPs) used in RNA therapeutics. Their approach combines validated laboratory protocols, reagents, and cloud-based software to measure critical quality attributes such as particle size and RNA encapsulation efficiency. The platform is designed to integrate with existing capillary electrophoresis (CE) and mass spectrometry (MS) systems, enabling standardized, scalable, and regulatorily compliant analytics without requiring new equipment purchases. RNAnalytics aims to streamline LNP characterization, simplify complex lab workflows, and provide reproducible data for developers of RNA and gene therapies.
Target Audience
RNAnalytics serves RNA startups, academic labs, CROs, CDMOs, biopharma companies, and industrial developers involved in RNA and gene therapy development.
Features
- Validated laboratory protocols for measuring critical quality parameters of LNPs, including particle size and RNA payload
- Reagents and reference materials for standardization across different CE and MS systems
- Cloud-based software for automated data analysis, Part 11-compliant report generation, and data management
- Scalable interfaces for integration into existing LIMS and production systems
- Streamlined workflows for formulation development, preclinical characterization, and GMP-near quality control
- AI-assisted data comparability and documentation for international regulatory authorities